Value proposition

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs through the discovery, development and commercialization of innovative medicines.

Since 2002, Incyte has been committed to the relentless pursuit of science to improve the lives of patients and drive meaningful advances in healthcare.

Incyte’s unique expertise in medicinal chemistry and biology has enabled us to build a portfolio of first-in-class medicines and a differentiated pipeline of therapies in Oncology and Inflammation & Autoimmunity, including Dermatology. The majority of our clinical candidates were discovered by Incyte scientists.

Headquartered in Wilmington, Delaware, Incyte has more than 2,600 employees and operations in North America, Europe and Asia.

We are proud to have been named a top five employer by Science magazine for 7 consecutive years, as well as being named one of America’s 100 Most Loved Workplaces and one of the Most Loved Global Workplaces by Newsweek.

For additional information on Incyte, please visit Incyte.com or follow us on social media: X, Instagram, Facebook, YouTube.

See our Community Guidelines: http://bit.ly/2sV0H5W

Oncology, Immuno-oncology, Targeted Therapy, Immunology, and Inflammation